| Bioactivity | Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer[1]. |
| In Vivo | Balugrastim (CG 10639) 具有很高的血浆稳定性和良好的耐受性[1]。 |
| Name | Balugrastim |
| CAS | 527698-09-5 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ghidini M, et al. New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim. Ther Clin Risk Manag. 2016 Jun 24;12:1009-15. |